Please login to the form below

Not currently logged in
Email:
Password:

transplant

This page shows the latest transplant news and features for those working in and with pharma, biotech and healthcare.

EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease

EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease

LentiGlobin is approved under the brand name Zynteglo in Europe for the treatment of dependent beta thalassaemia (TDT) who do not have a matching donor for a stem cell transplant.

Latest news

More from news
Approximately 8 fully matching, plus 250 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 17 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics